Patents by Inventor Kathy Bailey

Kathy Bailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for dark adaptation
    Patent number: 7470660
    Abstract: The present invention addresses the treatment of age-related macular degeneration, and treatment of individuals with impaired visual function such as impaired dark adaptation, using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, compositions that increase reverse cholesterol transport are utilized as therapeutic targets for age-related macular degeneration and improving impaired dark adaptation. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced by delivering Apolipoprotein A1, particularly a mimetic peptide.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: December 30, 2008
    Assignee: The Regents of the University of California
    Inventors: Daniel M. Schwartz, Keith G. Duncan, Kathy Bailey, John P. Kane, Brian Y. Ishida
  • Treatment for dark adaptation
    Publication number: 20050282750
    Abstract: The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, compositions that increase reverse cholesterol transport are utilized as therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced by delivering Apolipoprotein A1, particularly a mimetic peptide.
    Type: Application
    Filed: February 10, 2005
    Publication date: December 22, 2005
    Inventors: Daniel Schwartz, Keith Duncan, Kathy Bailey, John Kane, Brian Ishida
  • Treatment for age-related macular degeneration (AMD)
    Publication number: 20030162758
    Abstract: The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, reverse cholesterol transport components, such as transporters and HDL fractions, are utilized as diagnostic and therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced.
    Type: Application
    Filed: December 6, 2002
    Publication date: August 28, 2003
    Inventors: Daniel M. Schwartz, Keith Duncan, Kathy Bailey, John Kane, Brian Ishida